Silver Spike Investment Corp. (SSIC)

USD 10.74

(1.27%)

Operating Expenses Summary of Silver Spike Investment Corp.

  • Silver Spike Investment Corp.'s latest annual operating expenses in 2023 was 762.49 Thousand USD , down -67.4% from previous year.
  • Silver Spike Investment Corp.'s latest quarterly operating expenses in 2024 Q1 was 98.45 Million USD , up 27884.41% from previous quarter.
  • Silver Spike Investment Corp. reported a annual operating expenses of 2.33 Million USD in annual operating expenses 2022, up 852.9% from previous year.
  • Silver Spike Investment Corp. reported a annual operating expenses of 245.43 Thousand USD in annual operating expenses 2021, down -74.39% from previous year.
  • Silver Spike Investment Corp. reported a quarterly operating expenses of 775.63 Thousand USD for 2023 Q1, down -13.31% from previous quarter.
  • Silver Spike Investment Corp. reported a quarterly operating expenses of -354.35 Thousand USD for 2023 Q4, down -155.79% from previous quarter.

Annual Operating Expenses Chart of Silver Spike Investment Corp. (2023 - 2020)

Historical Annual Operating Expenses of Silver Spike Investment Corp. (2023 - 2020)

Year Operating Expenses Operating Expenses Growth
2023 762.49 Thousand USD -67.4%
2022 2.33 Million USD 852.9%
2021 245.43 Thousand USD -74.39%
2020 958.29 Thousand USD 0.0%

Peer Operating Expenses Comparison of Silver Spike Investment Corp.

Name Operating Expenses Operating Expenses Difference
Bright Green Corporation 8.25 Million USD 90.761%
Alpha Teknova, Inc. 45.85 Million USD 98.337%
ANI Pharmaceuticals, Inc. 195.98 Million USD 99.611%
Aquestive Therapeutics, Inc. 44.85 Million USD 98.3%
Collegium Pharmaceutical, Inc. 159.2 Million USD 99.521%
Cosmos Health Inc. 26.18 Million USD 97.088%
Journey Medical Corporation 54.59 Million USD 98.603%
Embecta Corp. 528.4 Million USD 99.856%
Esperion Therapeutics, Inc. 271.89 Million USD 99.72%
Dynavax Technologies Corporation 219.14 Million USD 99.652%
Intra-Cellular Therapies, Inc. 590 Million USD 99.871%
Pacira BioSciences, Inc. 326.37 Million USD 99.766%
PainReform Ltd. 9.58 Million USD 92.044%
Sunshine Biopharma, Inc. 13.12 Million USD 94.19%
Sunshine Biopharma, Inc. 13.12 Million USD 94.19%
SCYNEXIS, Inc. 51.84 Million USD 98.529%
Safety Shot Inc 12.1 Million USD 93.703%
China SXT Pharmaceuticals, Inc. 3.06 Million USD 75.157%
Procaps Group, S.A. 199.47 Million USD 99.618%
Theratechnologies Inc. 72.75 Million USD 98.952%
Harrow Health, Inc. 89.97 Million USD 99.153%
Sonoma Pharmaceuticals, Inc. 9.44 Million USD 91.928%
Biofrontera Inc. 39.95 Million USD 98.092%
DURECT Corporation 43.71 Million USD 98.256%
Supernus Pharmaceuticals, Inc. 529.01 Million USD 99.856%
Cronos Group Inc. 96.7 Million USD 99.212%
OptiNose, Inc. 85.1 Million USD 99.104%
Ironwood Pharmaceuticals, Inc. 232.12 Million USD 99.672%
Kala Pharmaceuticals, Inc. 39.15 Million USD 98.053%
RedHill Biopharma Ltd. -9.56 Million USD 107.975%
Organogenesis Holdings Inc. 314.13 Million USD 99.757%
Guardion Health Sciences, Inc. 9.73 Million USD 92.164%
Cumberland Pharmaceuticals Inc. 43.04 Million USD 98.228%
Radius Health, Inc. 265.92 Million USD 99.713%
Universe Pharmaceuticals INC 13.84 Million USD 94.491%
ProPhase Labs, Inc. 37.85 Million USD 97.986%
Phibro Animal Health Corporation 260.29 Million USD 99.707%
Procaps Group S.A. 187.24 Million USD 99.593%
Alvotech 285.43 Million USD 99.733%
TherapeuticsMD, Inc. 9.82 Million USD 92.239%
Viatris Inc. 5.96 Billion USD 99.987%
Rockwell Medical, Inc. 15.37 Million USD 95.04%
Aytu BioPharma, Inc. 59.84 Million USD 98.726%
SIGA Technologies, Inc. 22.04 Million USD 96.541%
Tilray Brands, Inc. 251.35 Million USD 99.697%
Lifecore Biomedical, Inc. 49.03 Million USD 98.445%
Shineco, Inc. 17.94 Million USD 95.752%
PetIQ, Inc. 192.72 Million USD 99.604%
Regencell Bioscience Holdings Limited 3.99 Million USD 80.895%
Incannex Healthcare Limited 30.05 Million USD 97.463%
Neurocrine Biosciences, Inc. 1.59 Billion USD 99.952%
Alimera Sciences, Inc. 62.64 Million USD 98.783%
Assertio Holdings, Inc. 368.58 Million USD 99.793%
Shuttle Pharmaceuticals Holdings, Inc. 5.88 Million USD 87.045%
Petros Pharmaceuticals, Inc. 17.8 Million USD 95.718%
Clever Leaves Holdings Inc. 21.16 Million USD 96.398%
Cyclo Therapeutics, Inc. 21.04 Million USD 96.376%
Avadel Pharmaceuticals plc 164.96 Million USD 99.538%
Hempacco Co., Inc. 7.59 Million USD 89.963%
Talphera, Inc. 11.99 Million USD 93.643%
Alvotech 285.43 Million USD 99.733%
Eagle Pharmaceuticals, Inc. 140.71 Million USD 99.458%
Lantheus Holdings, Inc. 344.9 Million USD 99.779%
Currenc Group, Inc. 24 Million USD 96.823%
Kamada Ltd. 45.42 Million USD 98.321%
Indivior PLC 911 Million USD 99.916%
Evoke Pharma, Inc. 12.4 Million USD 93.856%
Flora Growth Corp. 10.57 Million USD 92.792%
Cyclo Therapeutics, Inc. 21.04 Million USD 96.376%
Evolus, Inc. 189.75 Million USD 99.598%
HUTCHMED (China) Limited 436.23 Million USD 99.825%
Amphastar Pharmaceuticals, Inc. 154.13 Million USD 99.505%
Akanda Corp. 3.48 Million USD 78.111%